HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New alpha 2 globin chain variant with low oxygen affinity affecting the N-terminal residue and leading to N-acetylation [Hb Lyon-Bron alpha 1(NA1)Val --> Ac-Ala].

Abstract
Hemoglobin Lyon-Bron was found in two members of a family of German ascent presenting with a moderate normocytic anemia. In this alpha 2 globin variant, the N-terminal valine of the chain was replaced by an alanine. Electrospray mass spectrometry of the alpha chain showed that, as normally, the initiator methionine was cleaved during globin processing but that the N alpha-terminal group was totally acetylated. This resulted in structural modifications of a region crucial for oxygen binding. As a consequence, hemoglobin Lyon-Bron displayed both a reduced chloride effect and a decreased oxygen affinity, this last point explaining the apparent anemia.
AuthorsP Lacan, G Souillet, M Aubry, D Promé, S Richelme-David, J Kister, H Wajcman, A Francina
JournalAmerican journal of hematology (Am J Hematol) Vol. 69 Issue 3 Pg. 214-8 (Mar 2002) ISSN: 0361-8609 [Print] United States
PMID11891810 (Publication Type: Journal Article)
Chemical References
  • Hemoglobins, Abnormal
  • Ligands
  • Oxyhemoglobins
  • hemoglobin Lyon-Bron
  • Chlorine
  • Globins
  • Oxygen
Topics
  • Acetylation
  • Adolescent
  • Amino Acid Substitution
  • Binding Sites (genetics)
  • Chlorine (metabolism)
  • Family Health
  • Female
  • Genetic Variation
  • Globins (chemistry, genetics)
  • Hemoglobins, Abnormal (chemistry, genetics)
  • Humans
  • Hydrogen-Ion Concentration
  • Ligands
  • Male
  • Middle Aged
  • Oxygen (metabolism)
  • Oxyhemoglobins
  • Spectrometry, Mass, Electrospray Ionization
  • Titrimetry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: